bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

13,566 Articles (10,507 medRxiv, 3,059 bioRxiv)

Most recent first Previous |  Page 1341: Articles 13401-13410  | Next

Structure and immune recognition of the porcine epidemic diarrhea virus spike protein
Kirchdoerfer, R., Bhandari, M., Martini, O., Sewell, L. M., Bangaru, S., Yoon, K.-J., Ward, A.
10.1101/2020.02.18.955195 — Posted: 2020-02-19
Estimation of the final size of the coronavirus epidemic by the logistic model
batista, m.
10.1101/2020.02.16.20023606 — Posted: 2020-02-18
Evaluating new evidence in the early dynamics of the novel coronavirus COVID-19 outbreak in Wuhan, China with real time domestic traffic and potential asymptomatic transmissions
Zhou, C.
10.1101/2020.02.15.20023440 — Posted: 2020-02-18 Discussion: Onsite
When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis
zhang, l., wan, k., chen, j., lu, c., dong, l., wu, z.
10.1101/2020.02.16.20023804 — Posted: 2020-02-18
Risk map of the novel coronavirus (2019-nCoV) in China: proportionate control is needed
Li, X., Zhao, X., Lou, Y., Sun, Y.
10.1101/2020.02.16.20023838 — Posted: 2020-02-18
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., Xiong, L., Guo, C., Tian, J., Luo, J., Yao, J., Pang, R., Shen, H., Peng, C., Liu, T., Zhang, Q., Wu, J., Xu, L., Lu, S., Wang, B., Weng, Z., Han, C., Zhu, H., Zhou, R., Zhou, H., Chen, X., Ye, P., Zhu, B., He, S., He, Y., Jie, S., Wei, P., Zhang, J., Lu, Y., Wang, W., Zhang, L., Li, L., Zhou, F., Wang, J., Dittmer, U., Lu, M., Hu, Y., Yang, D., Zheng, X.
10.1101/2020.02.16.20023671 — Posted: 2020-02-18 Discussion: Onsite | Offsite
Simulating and Forecasting the Cumulative Confirmed Cases of SARS-CoV-2 in China by Boltzmann Function-based Regression Analyses
Fu, X., Ying, Q., Zeng, T., Long, T., Wang, Y.
10.1101/2020.02.16.20023564 — Posted: 2020-02-18 Discussion: Onsite
Estimating the Case Fatality Risk of COVID-19 using Cases from Outside China
Wilson, N., Kvalsvig, A., Telfar Barnard, L., Baker, M.
10.1101/2020.02.15.20023499 — Posted: 2020-02-18 Discussion: Onsite
Epidemic analysis of COVID-19 in China by dynamical modeling
Peng, L., Yang, W., Zhang, D., Zhuge, C., Hong, L.
10.1101/2020.02.16.20023465 — Posted: 2020-02-18 Discussion: Onsite
Epidemic Situation of Novel Coronavirus Pneumonia in China mainland
youbin, L., bao hong, L.
10.1101/2020.02.17.20024034 — Posted: 2020-02-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).